Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer

Approximately 20%–25% of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, resulting in an overexpression of the HER2 receptor. This overexpression is associated with aggressive disease, relatively poor prognosis, and worse clinical outcomes. N...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevcikova, Katarina, Vertakova-Krakovska, Bibiana, Spanik, Stanislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676960/
https://www.ncbi.nlm.nih.gov/pubmed/23762609
http://dx.doi.org/10.1155/2013/362467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676960/
https://www.ncbi.nlm.nih.gov/pubmed/23762609
http://dx.doi.org/10.1155/2013/362467

Ejemplares similares